首页 | 本学科首页   官方微博 | 高级检索  
     检索      

利奈唑胺治疗革兰氏阳性菌所致老年肺炎疗效观察
引用本文:刘彬,杨菊,后梅.利奈唑胺治疗革兰氏阳性菌所致老年肺炎疗效观察[J].西南科技大学学报(哲学社会科学版),2009,7(5):19-21.
作者姓名:刘彬  杨菊  后梅
作者单位:云南省昆明医学院第一附属医院干疗科,650032
摘    要:目的评价利奈唑胺注射液治疗革兰氏阳性球菌(均检出MRSA阳性)感染所致老年肺炎的临床疗效及安全性。方法老年肺炎25例,应用利奈唑胺治疗10~14天。结果本组患者平均应用11.21±2.65天,有效病例症状于4.7±1.8天缓解,体征7.1±2.9天好转。有效率88%,细菌清除率88%,未见明显不良反应。结论利奈唑胺治疗G+菌耐经菌株感染的老年肺炎疗效确切,安全性高。

关 键 词:利奈唑胺  G+菌  老年肺炎

Effect of Line Zonlid in Treatment of Eloderly Patients with Acquired Pneumonia by gram-positive bacteria
LIU Bin,YANG Ju,HOU Mei.Effect of Line Zonlid in Treatment of Eloderly Patients with Acquired Pneumonia by gram-positive bacteria[J].Journal of Southwest University of Science and Technology,2009,7(5):19-21.
Authors:LIU Bin  YANG Ju  HOU Mei
Institution:(Department of senior cadres ,First Teaching Hospital of Kunming Medical College, Yunnan 650032)
Abstract:Objective To evaluate the clinical officacy of linezolid in the treatment of elderly patients with acquired pneumonia by gram-positive bacteria(G*^+MRSA+). Method 25 elderly patients with acquaired pneumonia by G+ were given linezolid for a course of 10-14 days. Results In this group,the linezolid treatment ranged an average time of 11.21±2.65 days. In the cured cases relief was obtained in 4.7±1.8 days. Improvement of vital signs appeared 7.1±2.9:days,and the efficacy rate was 88%,the bacteria's delete rate was 88%,No serious reaction was noticed in the cases. Conclusion Linezolid is effective and safe in treatment of CAP and HAP by G^+which against antimicrobic in elderly patients.
Keywords:Linezolid  Gram-positive bacteria  Elderly patient with pneumonia
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号